Monoclonal Antibody Therapy in Haematological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|5|3|148-159

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.3, 2010-08, pp. : 148-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis regulating proteins as targets of therapy for haematological malignancies

By Kornblau S.M.   Konopleva M.   Andreeff M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2027-2057

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibody conjugates in cancer therapy

By  

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Advances in the treatment for haematological malignancies

By Piccaluga Pier Paolo   Martinelli Giovanni   Baccarani Michele  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

Antineoplastics: Secondary haematological malignancies following breast cancer therapy: 6 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1083, 2006-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004

By Haas Maureen   Lonial Sagar  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1161-1169

Informa Healthcare

Access to resources Recommend Favorite